Atypical protein kinase C inhibitors abrogate malignant breast cancer

被引：0
|
作者：
Oishee, Nuzhat Nowshin
Khalid, Khandker Mohammad
Acevedo-Duncan, Dr. Mildred
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5022
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Atypical protein kinases C-ζ and ι-inhibitors impede the growth of malignant gastric cancer cells
    Shourav, Abiral Hasib
    Marzan, Mahfuza
    Khalid, Khandker Mohammad
    Ratnayake, Wishrawana Sarathi
    Acevedo-Duncan, Mildred
    CANCER RESEARCH, 2024, 84 (06)
  • [2] Atypical protein kinase c inhibitors can repress epithelial to mesenchymal transition (type III) in malignant melanoma
    Ratnayake, Wishrawana Sarathi
    Acevedo-Duncan, Mildred
    CANCER RESEARCH, 2017, 77
  • [3] Atypical protein kinase C inhibitors can repress epithelial to mesenchymal transition (Type III) in malignant melanoma
    Ratnayake, Wishrawana Sarathi
    Acevedo-Duncan, Mildred
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S11 - S11
  • [4] Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma
    Chen, TC
    Su, S
    Fry, D
    Liebes, L
    CANCER, 2003, 97 (09) : 2363 - 2373
  • [5] Nicotine enhances the malignant potential of human pancreatic cancer cells via activation of atypical protein kinase C
    Hanaki, Takehiko
    Horikoshi, Yosuke
    Nakaso, Kazuhiro
    Nakasone, Masato
    Kitagawa, Yoshinori
    Amisaki, Masataka
    Arai, Yosuke
    Tokuyasu, Naruo
    Sakamoto, Teruhisa
    Honjo, Soichiro
    Saito, Hiroaki
    Ikeguchi, Masahide
    Yamashita, Kazunari
    Ohno, Shigeo
    Matsura, Tatsuya
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (11): : 2404 - 2415
  • [6] The overexpression and altered localization of the atypical protein kinase C λ/ι in breast cancer correlates with the pathologic type of these tumors
    Kojima, Yasuyuki
    Akimoto, Kazunori
    Nagashima, Yoji
    Ishiguro, Hitoshi
    Shirai, Sumiko
    Chishima, Takashi
    Ichikawa, Yasushi
    Ishikawa, Takashi
    Sasaki, Takeshi
    Kubota, Yoshinobu
    Inayama, Yoshiaki
    Aoki, Ichiro
    Ohno, Shigeo
    Shimada, Hiroshi
    HUMAN PATHOLOGY, 2008, 39 (06) : 824 - 831
  • [7] New protein kinase inhibitors in breast cancer: afatinib and neratinib
    Zhang, Xiaosong
    Munster, Pamela N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (09) : 1277 - 1288
  • [8] A biophysical investigation into the binding interactions of novel anti-cancer inhibitors of atypical protein kinase C (aPKCs)
    Noor, Radwan Ebna
    Smalley, Tracess B.
    Acevedo-Duncan, Mildred
    CANCER RESEARCH, 2023, 83 (07)
  • [9] Identification and characterisation of small molecule inhibitors of atypical protein kinase C (aPKC) as anti-cancer agents
    Barton, C.
    Soudy, C.
    Wynne, E.
    Patel, B.
    Kaye, S.
    Lejeune, A.
    East, P.
    Parker, P.
    Dillon, C.
    Roffey, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 127 - 127
  • [10] Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells
    Mao, ML
    Fang, XJ
    Lu, YL
    LaPushin, R
    Bast, RC
    Mills, GB
    BIOCHEMICAL JOURNAL, 2000, 352 : 475 - 482
12345